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229, 233, 241, 245, 247, and 249.doi:10.1016/j.jtcvs.2006.03.041he ultimate goal of clinical research is to provide the best information to
optimally guide the management of a given patient with a particular problem
confronting us. Specifically, surgeons might wish to compare medications,
urgical techniques, or combinations thereof for a given condition. Randomized
ontrolled trials (RCTs) help to circumvent several major obstacles hindering
nvestigations of this nature. Through randomization, selection bias is theoretically
emoved, and confounding factors are distributed evenly among groups to mitigate
heir potential influences. Hence RCTs have emerged as the most efficient and
igorous way to generate robust scientific evidence of safety and efficacy necessary
o prove whether a therapeutic intervention works.
However, such trials are expensive, time consuming, difficult to perform, and
otentially dangerous. They are obviously not the only way to determine whether a
iven therapeutic intervention is efficacious.
Surgery has been progressing for thousands of years, with effective procedures
eing adopted and ineffective procedures discarded without the benefit of RCTs,
hich are a relative newcomer.
From a pragmatic perspective, many surgical disorders and procedures are not
menable to study by RCTs because of small numbers, which make the length of
ime required to accrue an adequate number of cases too long. Indeed, critical
nalyses of negative results of RCTs published in the surgical literature demonstrate
hat many reports with negative results lack sufficient statistical power to defini-
ively support or refute the null hypothesis at hand.1 Furthermore, these difficultie
re compounded by the acceleration and evolution of technology.
There is a hierarchy in the development of information to decide whether an
ntervention is beneficial. Anecdotal evidence from a small number of patients is
rovided by case reports. Suggestive evidence is provided by case series, usually
etrospective analysis from a single institution. Supportive evidence is provided by
bservational studies–open trials–epidemiologic surveys of a large number of cases
rom many institutions where data are collected prospectively in a standardized
ormat. Lastly, there is the sage advice of a wise and experienced surgeon. This
hould not be neglected in our compulsion to worship at the altar of more rigorous
cientific studies.
Before embarking on a randomized clinical trial, there must be adequate sup-
ortive evidence not only concerning the safety and effectiveness of the procedure
ut also of the group that is serving as the baseline. This supportive evidence is
rovided by the epidemiologic survey open trial or observational study. In many
nstances a rigorously conducted epidemiologic survey will obviate the need for a
andomized trial. And, as noted above, in many instances of surgical procedures,
andomized clinical trials are simply not feasible.
The following are caveats applicable to the design and conduct of RCTs:
● Sample size. No trial ever failed because of too many cases.
● Exploratory analysis. Not infrequently, the most valuable data about the
procedure or about the disease being studied will be found in subgroups during
exploratory analyses that were not anticipated at the time of study design. This
improves data information about the patient population and their disease, as
well as the procedure.
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TS● Organization. Beware of trials of surgical procedu
organized by nonsurgeons.
● Outcome measures. Despite pressure from regul
tory authorities to choose a single end point
reality multiple end points are important. This 
cludes compound end points involving a combi
tion of end points. End points need to be evalu
by individuals who are blind to the procedure 
independent to the management of the patien
Ideally, they should be individuals who have 
vested interest in whether the procedure being s
ied works.
It is also important to heed the key messages conv
y Tiruvoipati and colleagues2 in the current article. 
eurosurgery, particularly in certain complex cranial b
ases, we emphasize that it is important to plan the closur
3
44 The Journal of Thoracic and Cardiovascular Surgery ● Auguefore the opening. Similarly, planning of the reportin
n RCT during all phases of the trial is important. Atte
o all of these aforementioned details and improvemen
he quality of reporting as we move forward might help to
ake the “comic opera” stigma3 ssociated with research i
urgery a thing of the past.
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